Lung-I Cheng
Vice President, Cell and Gene Therapy • AmerisourceBergen
Lung-I Cheng is Vice President, Cell and Gene Therapy, leading AmerisourceBergen’s Cell and Gene Therapy (CGT) service line within Commercial Solutions.
He is responsible for leading a unified CGT go-to-market strategy that addresses external customer needs, and provides integrated solutions that deliver the right resources at the right time to position therapies for success.
Before joining AmerisourceBergen, he spent a decade in biopharma and most recently led Takeda Oncology’s global value and access team in cell therapies and pipeline.
Also Speaking
Leonardo M.R. Ferreira
Assistant Professor of Microbiology and Immunology • Medical University of South Carolina
8 January 2023
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023
